IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 148 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,959,299 | -7.9% | 307,300 | +1.8% | 0.00% | 0.0% |
| Q2 2023 | $3,213,280 | +2.5% | 302,000 | +1.3% | 0.00% | 0.0% |
| Q1 2023 | $3,134,960 | -24.0% | 298,000 | -10.5% | 0.00% | -33.3% |
| Q4 2022 | $4,125,870 | +21.3% | 333,000 | +1.4% | 0.00% | +50.0% |
| Q3 2022 | $3,401,000 | -12.6% | 328,300 | -2.8% | 0.00% | -33.3% |
| Q2 2022 | $3,893,000 | -15.8% | 337,600 | -8.2% | 0.00% | 0.0% |
| Q1 2022 | $4,624,000 | +16.6% | 367,600 | +8.1% | 0.00% | +50.0% |
| Q4 2021 | $3,964,000 | -10.7% | 340,000 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $4,440,000 | +2.4% | 340,000 | +0.9% | 0.00% | 0.0% |
| Q2 2021 | $4,338,000 | +11.7% | 337,100 | -3.0% | 0.00% | 0.0% |
| Q1 2021 | $3,885,000 | -0.6% | 347,500 | +1.3% | 0.00% | 0.0% |
| Q4 2020 | $3,909,000 | +26.6% | 343,200 | 0.0% | 0.00% | +50.0% |
| Q3 2020 | $3,087,000 | -10.8% | 343,200 | +2.3% | 0.00% | -33.3% |
| Q2 2020 | $3,462,000 | +12.8% | 335,500 | +10.3% | 0.00% | 0.0% |
| Q1 2020 | $3,068,000 | -23.0% | 304,100 | +1.5% | 0.00% | -25.0% |
| Q4 2019 | $3,986,000 | +59.0% | 299,500 | +2.6% | 0.00% | +33.3% |
| Q3 2019 | $2,507,000 | -20.3% | 292,000 | +1.5% | 0.00% | 0.0% |
| Q2 2019 | $3,147,000 | -8.9% | 287,700 | +12.7% | 0.00% | -25.0% |
| Q1 2019 | $3,454,000 | +35.5% | 255,300 | +3.7% | 0.00% | +33.3% |
| Q4 2018 | $2,550,000 | -47.8% | 246,100 | -7.0% | 0.00% | -40.0% |
| Q3 2018 | $4,883,000 | +7.2% | 264,500 | +11.0% | 0.01% | 0.0% |
| Q2 2018 | $4,556,000 | +32.1% | 238,300 | +6.6% | 0.01% | +25.0% |
| Q1 2018 | $3,449,000 | +5.2% | 223,500 | +2.2% | 0.00% | 0.0% |
| Q4 2017 | $3,277,000 | -1.3% | 218,600 | +3.8% | 0.00% | 0.0% |
| Q3 2017 | $3,320,000 | -16.5% | 210,500 | 0.0% | 0.00% | -20.0% |
| Q2 2017 | $3,974,000 | +13.5% | 210,500 | +2.5% | 0.01% | +25.0% |
| Q1 2017 | $3,502,000 | +12.9% | 205,300 | +1.2% | 0.00% | -20.0% |
| Q4 2016 | $3,102,000 | +1.4% | 202,900 | +5.3% | 0.01% | 0.0% |
| Q3 2016 | $3,058,000 | +17.8% | 192,600 | -3.0% | 0.01% | +25.0% |
| Q2 2016 | $2,597,000 | +19.6% | 198,600 | -3.5% | 0.00% | 0.0% |
| Q1 2016 | $2,172,000 | +14.7% | 205,800 | +26.0% | 0.00% | -20.0% |
| Q4 2015 | $1,893,000 | +11.2% | 163,300 | 0.0% | 0.01% | +25.0% |
| Q3 2015 | $1,702,000 | -0.4% | 163,300 | +15.3% | 0.00% | 0.0% |
| Q2 2015 | $1,708,000 | -19.4% | 141,600 | +6.9% | 0.00% | -33.3% |
| Q1 2015 | $2,118,000 | +7.4% | 132,400 | +2.9% | 0.01% | -14.3% |
| Q4 2014 | $1,972,000 | +21.3% | 128,700 | +2.5% | 0.01% | +16.7% |
| Q3 2014 | $1,626,000 | -15.5% | 125,500 | 0.0% | 0.01% | -14.3% |
| Q2 2014 | $1,924,000 | +24.5% | 125,500 | 0.0% | 0.01% | +16.7% |
| Q1 2014 | $1,546,000 | +53.5% | 125,500 | +44.8% | 0.01% | +50.0% |
| Q4 2013 | $1,007,000 | +11.6% | 86,700 | +13.9% | 0.00% | 0.0% |
| Q3 2013 | $902,000 | +12.6% | 76,100 | -5.5% | 0.00% | 0.0% |
| Q2 2013 | $801,000 | – | 80,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
| AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
| Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
| Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
| Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
| SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
| BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
| AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
| EMC Capital Management | 43,315 | $417 | 0.31% |